This report provides a comprehensive analysis of the global PTCA and PTA balloon catheter market, forecasting significant growth through 2032. It examines essential devices used in minimally invasive vascular therapies, segmenting the industry by type, application, and geography. Driven by aging populations and rising chronic diseases, the market is evolving toward specialized, high-performance technologies and integrated drug-delivery platforms. The study further evaluates competitive dynamics, regional trends, and key manufacturers to identify emerging opportunities and strategic growth drivers.

Market Overview

The global PTCA and PTA Balloon Catheter market is projected to experience significant growth, increasing from US$ 2813 million in 2025 to US$ 4408 million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2032.

Product Definition and Functionality

PTCA and PTA balloon catheters are essential devices used in percutaneous transluminal angioplasty procedures, targeting coronary and peripheral arteries respectively:

• PTCA Balloon Catheters: Specifically designed for treating stenosis or occlusion within the coronary arteries.
• PTA Balloon Catheters: Utilized for dilating lesions in peripheral vessels, such as those located in the limbs, renal arteries, or carotid arteries.

Key Distinctions: While similar in function, these devices differ in design, dimensions, and pressure tolerance to accommodate the specific anatomical and pathological variations between coronary and peripheral vasculature. They serve as fundamental tools in modern minimally invasive vascular therapies.

Market Dynamics

Current Market Status

PTCA and PTA balloon catheters are currently widely used in minimally invasive interventions for cardiovascular and peripheral arterial diseases on a global scale.

• Growth Drivers: The demand for percutaneous angioplasty is rapidly increasing, driven by an aging population and the rising incidence of chronic conditions such as diabetes and hypertension.
• Regional Trends:
• Developed Markets: Characterized by the dominance of high-performance, precision-oriented balloon catheters due to advanced technologies and clinical expertise.
• Emerging Economies: Experiencing rapid growth fueled by improvements in healthcare infrastructure and the expansion of public reimbursement schemes.

Future Trends and Technological Evolution

Looking forward, technologies will evolve toward greater specialization and personalization:

• PTCA Balloon Evolution: Emphasis will be placed on high-pressure tolerance, low compliance, small profiles, and enhanced trackability to address complex coronary lesions.
• PTA Balloon Evolution: Focus will shift toward long lesion coverage, distal vessel access, and addressing peripheral-specific anatomical challenges through extended shaft lengths, softer materials, and improved torque control.
• Hybrid Platforms: The integration of drug delivery (DCBs) and image-guided precision is expected to transform these devices from simple dilatation tools into hybrid therapeutic platforms.

Market Headwinds and Challenges

Despite promising prospects, the market faces several challenges:

• Price Competition: Intensifying competition, particularly in regions implementing centralized procurement, is putting pressure on profit margins.
• Awareness and Adoption: In lower-resource settings, awareness of minimally invasive procedures remains limited, and the adoption of advanced devices at primary healthcare levels is lagging.
• Imaging Limitations: Limited access to intraprocedural imaging tools, such as OCT or IVUS, prevents clinicians from fully recognizing the value of premium balloon technologies.
• Strategic Requirements: To ensure sustainable growth, manufacturers must focus on product differentiation, investment in clinical education, and the development of integrated therapeutic ecosystems.

Report Scope and Methodology

Produced by LP Information, Inc. (LPI), the “PTCA and PTA Balloon Catheter Industry Forecast” provides a comprehensive analysis of the global landscape.

• Content Coverage: The report reviews total world PTCA and PTA Balloon Catheter sales in 2025 and provides projected sales analysis for 2026 through 2032.
• Analytical Depth: It includes detailed analysis in US$ millions, covering product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Strategic Insights: The report analyzes leading global companies regarding their portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Methodology: The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the market's current state and future trajectory.

Market Segmentation

By Type

• PTCA Balloon Catheter
• PTA Balloon Catheter

By Application

• Hospital
• Clinic
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key companies profiled in this report have been selected based on primary expert input and analysis of company coverage, product portfolio, and market penetration:

• Abbott
• Alvimedica
• APT Medical
• Avimedica
• B. Braun
• Biotronik
• Bluesail
• Boston Scientific
• BrosMed Medical
• Cordis
• Demax Medical
• DK Medical Technology
• GENOSS
• Hexacath
• HengYi Medical
• InSitu Technologies
• KANEKA
• Lepu Medical
• Medoo Medical
• Medtronic
• MicroPort
• Nanjing YDB Medical
• OrbusNeich Medical
• Shanghai INT Medical
• Sinomed
• Shunmei Medical
• Terumo
• Translumina
• Zhejiang Barty Medical
• Yinyi Biotech

Key Questions Addressed

• What is the 10-year outlook for the global PTCA and PTA Balloon Catheter market?
• What factors are driving PTCA and PTA Balloon Catheter market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do PTCA and PTA Balloon Catheter market opportunities vary by end market size?
• How does PTCA and PTA Balloon Catheter break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global PTCA and PTA Balloon Catheter Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for PTCA and PTA Balloon Catheter by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for PTCA and PTA Balloon Catheter by Country/Region, 2021, 2025 & 2032

  • 2.2 PTCA and PTA Balloon Catheter Segment by Type

    • 2.2.1 PTCA Balloon Catheter

    • 2.2.2 PTA Balloon Catheter

    • 2.2.3 PTCA and PTA Balloon Catheter Sales by Type

      • 2.2.3.1 Global PTCA and PTA Balloon Catheter Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global PTCA and PTA Balloon Catheter Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global PTCA and PTA Balloon Catheter Sale Price by Type (2021-2026)

  • 2.3 PTCA and PTA Balloon Catheter Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Others

    • 2.3.4 PTCA and PTA Balloon Catheter Sales by Application

      • 2.3.4.1 Global PTCA and PTA Balloon Catheter Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global PTCA and PTA Balloon Catheter Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global PTCA and PTA Balloon Catheter Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global PTCA and PTA Balloon Catheter Breakdown Data by Company

    • 3.1.1 Global PTCA and PTA Balloon Catheter Annual Sales by Company (2021-2026)

    • 3.1.2 Global PTCA and PTA Balloon Catheter Sales Market Share by Company (2021-2026)

  • 3.2 Global PTCA and PTA Balloon Catheter Annual Revenue by Company (2021-2026)

    • 3.2.1 Global PTCA and PTA Balloon Catheter Revenue by Company (2021-2026)

    • 3.2.2 Global PTCA and PTA Balloon Catheter Revenue Market Share by Company (2021-2026)

  • 3.3 Global PTCA and PTA Balloon Catheter Sale Price by Company

  • 3.4 Key Manufacturers PTCA and PTA Balloon Catheter Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers PTCA and PTA Balloon Catheter Product Location Distribution

    • 3.4.2 Players PTCA and PTA Balloon Catheter Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for PTCA and PTA Balloon Catheter by Geographic Region

  • 4.1 World Historic PTCA and PTA Balloon Catheter Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global PTCA and PTA Balloon Catheter Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global PTCA and PTA Balloon Catheter Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic PTCA and PTA Balloon Catheter Market Size by Country/Region (2021-2026)

    • 4.2.1 Global PTCA and PTA Balloon Catheter Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global PTCA and PTA Balloon Catheter Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas PTCA and PTA Balloon Catheter Sales Growth

  • 4.4 APAC PTCA and PTA Balloon Catheter Sales Growth

  • 4.5 Europe PTCA and PTA Balloon Catheter Sales Growth

  • 4.6 Middle East & Africa PTCA and PTA Balloon Catheter Sales Growth

• 5 Americas

  • 5.1 Americas PTCA and PTA Balloon Catheter Sales by Country

    • 5.1.1 Americas PTCA and PTA Balloon Catheter Sales by Country (2021-2026)

    • 5.1.2 Americas PTCA and PTA Balloon Catheter Revenue by Country (2021-2026)

  • 5.2 Americas PTCA and PTA Balloon Catheter Sales by Type (2021-2026)

  • 5.3 Americas PTCA and PTA Balloon Catheter Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC PTCA and PTA Balloon Catheter Sales by Region

    • 6.1.1 APAC PTCA and PTA Balloon Catheter Sales by Region (2021-2026)

    • 6.1.2 APAC PTCA and PTA Balloon Catheter Revenue by Region (2021-2026)

  • 6.2 APAC PTCA and PTA Balloon Catheter Sales by Type (2021-2026)

  • 6.3 APAC PTCA and PTA Balloon Catheter Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe PTCA and PTA Balloon Catheter by Country

    • 7.1.1 Europe PTCA and PTA Balloon Catheter Sales by Country (2021-2026)

    • 7.1.2 Europe PTCA and PTA Balloon Catheter Revenue by Country (2021-2026)

  • 7.2 Europe PTCA and PTA Balloon Catheter Sales by Type (2021-2026)

  • 7.3 Europe PTCA and PTA Balloon Catheter Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa PTCA and PTA Balloon Catheter by Country

    • 8.1.1 Middle East & Africa PTCA and PTA Balloon Catheter Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa PTCA and PTA Balloon Catheter Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa PTCA and PTA Balloon Catheter Sales by Type (2021-2026)

  • 8.3 Middle East & Africa PTCA and PTA Balloon Catheter Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of PTCA and PTA Balloon Catheter

  • 10.3 Manufacturing Process Analysis of PTCA and PTA Balloon Catheter

  • 10.4 Industry Chain Structure of PTCA and PTA Balloon Catheter

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 PTCA and PTA Balloon Catheter Distributors

  • 11.3 PTCA and PTA Balloon Catheter Customer

• 12 World Forecast Review for PTCA and PTA Balloon Catheter by Geographic Region

  • 12.1 Global PTCA and PTA Balloon Catheter Market Size Forecast by Region

    • 12.1.1 Global PTCA and PTA Balloon Catheter Forecast by Region (2027-2032)

    • 12.1.2 Global PTCA and PTA Balloon Catheter Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global PTCA and PTA Balloon Catheter Forecast by Type (2027-2032)

  • 12.7 Global PTCA and PTA Balloon Catheter Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Boston Scientific

    • 13.1.1 Boston Scientific Company Information

    • 13.1.2 Boston Scientific PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.1.3 Boston Scientific PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Boston Scientific Main Business Overview

    • 13.1.5 Boston Scientific Latest Developments

  • 13.2 Abbott

    • 13.2.1 Abbott Company Information

    • 13.2.2 Abbott PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.2.3 Abbott PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Abbott Main Business Overview

    • 13.2.5 Abbott Latest Developments

  • 13.3 Medtronic

    • 13.3.1 Medtronic Company Information

    • 13.3.2 Medtronic PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.3.3 Medtronic PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Medtronic Main Business Overview

    • 13.3.5 Medtronic Latest Developments

  • 13.4 Terumo

    • 13.4.1 Terumo Company Information

    • 13.4.2 Terumo PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.4.3 Terumo PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Terumo Main Business Overview

    • 13.4.5 Terumo Latest Developments

  • 13.5 Bluesail

    • 13.5.1 Bluesail Company Information

    • 13.5.2 Bluesail PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.5.3 Bluesail PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Bluesail Main Business Overview

    • 13.5.5 Bluesail Latest Developments

  • 13.6 B. Braun

    • 13.6.1 B. Braun Company Information

    • 13.6.2 B. Braun PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.6.3 B. Braun PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 B. Braun Main Business Overview

    • 13.6.5 B. Braun Latest Developments

  • 13.7 Acrostak

    • 13.7.1 Acrostak Company Information

    • 13.7.2 Acrostak PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.7.3 Acrostak PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Acrostak Main Business Overview

    • 13.7.5 Acrostak Latest Developments

  • 13.8 KANEKA

    • 13.8.1 KANEKA Company Information

    • 13.8.2 KANEKA PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.8.3 KANEKA PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 KANEKA Main Business Overview

    • 13.8.5 KANEKA Latest Developments

  • 13.9 GENOSS

    • 13.9.1 GENOSS Company Information

    • 13.9.2 GENOSS PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.9.3 GENOSS PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 GENOSS Main Business Overview

    • 13.9.5 GENOSS Latest Developments

  • 13.10 Biotronik

    • 13.10.1 Biotronik Company Information

    • 13.10.2 Biotronik PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.10.3 Biotronik PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Biotronik Main Business Overview

    • 13.10.5 Biotronik Latest Developments

  • 13.11 Alvimedica

    • 13.11.1 Alvimedica Company Information

    • 13.11.2 Alvimedica PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.11.3 Alvimedica PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Alvimedica Main Business Overview

    • 13.11.5 Alvimedica Latest Developments

  • 13.12 Translumina

    • 13.12.1 Translumina Company Information

    • 13.12.2 Translumina PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.12.3 Translumina PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Translumina Main Business Overview

    • 13.12.5 Translumina Latest Developments

  • 13.13 Cordis

    • 13.13.1 Cordis Company Information

    • 13.13.2 Cordis PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.13.3 Cordis PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Cordis Main Business Overview

    • 13.13.5 Cordis Latest Developments

  • 13.14 Balton

    • 13.14.1 Balton Company Information

    • 13.14.2 Balton PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.14.3 Balton PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 Balton Main Business Overview

    • 13.14.5 Balton Latest Developments

  • 13.15 Hexacath

    • 13.15.1 Hexacath Company Information

    • 13.15.2 Hexacath PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.15.3 Hexacath PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Hexacath Main Business Overview

    • 13.15.5 Hexacath Latest Developments

  • 13.16 InSitu Technologies

    • 13.16.1 InSitu Technologies Company Information

    • 13.16.2 InSitu Technologies PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.16.3 InSitu Technologies PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 InSitu Technologies Main Business Overview

    • 13.16.5 InSitu Technologies Latest Developments

  • 13.17 MicroPort

    • 13.17.1 MicroPort Company Information

    • 13.17.2 MicroPort PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.17.3 MicroPort PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 MicroPort Main Business Overview

    • 13.17.5 MicroPort Latest Developments

  • 13.18 APT Medical

    • 13.18.1 APT Medical Company Information

    • 13.18.2 APT Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.18.3 APT Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.18.4 APT Medical Main Business Overview

    • 13.18.5 APT Medical Latest Developments

  • 13.19 BrosMed Medical

    • 13.19.1 BrosMed Medical Company Information

    • 13.19.2 BrosMed Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.19.3 BrosMed Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.19.4 BrosMed Medical Main Business Overview

    • 13.19.5 BrosMed Medical Latest Developments

  • 13.20 OrbusNeich Medical

    • 13.20.1 OrbusNeich Medical Company Information

    • 13.20.2 OrbusNeich Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.20.3 OrbusNeich Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.20.4 OrbusNeich Medical Main Business Overview

    • 13.20.5 OrbusNeich Medical Latest Developments

  • 13.21 Lepu Medical

    • 13.21.1 Lepu Medical Company Information

    • 13.21.2 Lepu Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.21.3 Lepu Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.21.4 Lepu Medical Main Business Overview

    • 13.21.5 Lepu Medical Latest Developments

  • 13.22 Shunmei Medical

    • 13.22.1 Shunmei Medical Company Information

    • 13.22.2 Shunmei Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.22.3 Shunmei Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.22.4 Shunmei Medical Main Business Overview

    • 13.22.5 Shunmei Medical Latest Developments

  • 13.23 Shanghai INT Medical

    • 13.23.1 Shanghai INT Medical Company Information

    • 13.23.2 Shanghai INT Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.23.3 Shanghai INT Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.23.4 Shanghai INT Medical Main Business Overview

    • 13.23.5 Shanghai INT Medical Latest Developments

  • 13.24 Sinomed

    • 13.24.1 Sinomed Company Information

    • 13.24.2 Sinomed PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.24.3 Sinomed PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.24.4 Sinomed Main Business Overview

    • 13.24.5 Sinomed Latest Developments

  • 13.25 Nanjing YDB Medical

    • 13.25.1 Nanjing YDB Medical Company Information

    • 13.25.2 Nanjing YDB Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.25.3 Nanjing YDB Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.25.4 Nanjing YDB Medical Main Business Overview

    • 13.25.5 Nanjing YDB Medical Latest Developments

  • 13.26 Zhejiang Barty Medical

    • 13.26.1 Zhejiang Barty Medical Company Information

    • 13.26.2 Zhejiang Barty Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.26.3 Zhejiang Barty Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.26.4 Zhejiang Barty Medical Main Business Overview

    • 13.26.5 Zhejiang Barty Medical Latest Developments

  • 13.27 Medoo Medical

    • 13.27.1 Medoo Medical Company Information

    • 13.27.2 Medoo Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.27.3 Medoo Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.27.4 Medoo Medical Main Business Overview

    • 13.27.5 Medoo Medical Latest Developments

  • 13.28 Yinyi Biotech

    • 13.28.1 Yinyi Biotech Company Information

    • 13.28.2 Yinyi Biotech PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.28.3 Yinyi Biotech PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.28.4 Yinyi Biotech Main Business Overview

    • 13.28.5 Yinyi Biotech Latest Developments

  • 13.29 HengYi Medical

    • 13.29.1 HengYi Medical Company Information

    • 13.29.2 HengYi Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.29.3 HengYi Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.29.4 HengYi Medical Main Business Overview

    • 13.29.5 HengYi Medical Latest Developments

  • 13.30 Demax Medical

    • 13.30.1 Demax Medical Company Information

    • 13.30.2 Demax Medical PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.30.3 Demax Medical PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.30.4 Demax Medical Main Business Overview

    • 13.30.5 Demax Medical Latest Developments

  • 13.31 DK Medical Technology

    • 13.31.1 DK Medical Technology Company Information

    • 13.31.2 DK Medical Technology PTCA and PTA Balloon Catheter Product Portfolios and Specifications

    • 13.31.3 DK Medical Technology PTCA and PTA Balloon Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.31.4 DK Medical Technology Main Business Overview

    • 13.31.5 DK Medical Technology Latest Developments

• 14 Research Findings and Conclusion